High Throughput Screening (HTS) is a drug discovery process that uses automation to quickly assay large numbers of compounds, often over 50,000 per day. The goal of HTS is to identify hits or leads that modify a biological target in the desired manner at low concentrations, and may represent new structures. HTS assays use various detection methods like spectroscopy, chromatography, and calorimetry to rapidly screen libraries of natural products, combinatorial compounds, and other drug-like molecules in order to discover novel bioactive agents.